Enteric Fever Caused bySalmonella entericaSerovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal
Open Access
- 6 November 2017
- journal article
- research article
- Published by Hindawi Limited in International Journal of Microbiology
- Vol. 2017, 1-6
- https://doi.org/10.1155/2017/2869458
Abstract
Enteric fever continues to be an important public health problem especially in developing countries of the tropical region including Nepal. In this study, we aimed to investigate the incidence of enteric fever associated withSalmonella entericaand determine its antimicrobial susceptibilities to therapeutic antimicrobials in a community based teaching hospital of Nepal. A total of 2,304 blood samples from suspected enteric fever patients attending Manmohan Memorial Teaching Hospital were processed with standard microbiological methods for the isolation and identification of bacterial pathogens. TheSalmonella entericaclinical strains were subjected to antimicrobial susceptibility testing by Kirby–Bauer disk diffusion method, and the results were interpreted according to the criteria suggested by the Clinical and Laboratory Standards Institute (CLSI). A total of 245 (10.6%) cases of enteric fever associated withSalmonella entericawere confirmed by blood culture. Out of them, 162 (66.1%) were caused bySalmonellaTyphi and 83 (33.9%) bySalmonellaParatyphi. On Kirby–Bauer disk diffusion antimicrobial susceptibility testing,Salmonellaisolates were highly susceptible to cefixime (100%), ceftriaxone (100%), ampicillin (97.9%), cotrimoxazole (94.6%), azithromycin (96.7%), tetracycline (95.5%), and chloramphenicol (97.5%), respectively. Two hundred twenty-six (92.2%) ofSalmonellaisolates were nalidixic acid resistant with reduced susceptibility to ciprofloxacin (36.7%) and ofloxacin (54.8%), respectively. Although the rate of MDRSalmonellastrains was very low (<5%), their reduced susceptibility to fluoroquinolones has restricted their routine empirical use. Third generation cephalosporins are the safest choice for empirical use but ampicillin, cotrimoxazole, azithromycin, and chloramphenicol can be effective alternatives.Keywords
This publication has 39 references indexed in Scilit:
- Identification of Immunogenic Salmonella enterica Serotype Typhi Antigens Expressed in Chronic Biliary Carriers of S. Typhi in Kathmandu, NepalPLoS Neglected Tropical Diseases, 2013
- In Vitro Susceptibility Testing of Fluoroquinolone Activity Against Salmonella: Recent Changes to CLSI StandardsClinical Infectious Diseases, 2012
- Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005–2009Clinical Microbiology & Infection, 2012
- Blood Stream Infections among febrile patients attending a Teaching Hospital in Western Region of NepalAustralasian Medical Journal, 2010
- Global Trends in Typhoid and Paratyphoid FeverClinical Infectious Diseases, 2010
- Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the FluoroquinolonesAntimicrobial Agents and Chemotherapy, 2007
- Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003Diagnostic Microbiology and Infectious Disease, 2006
- Changing trends in the antibiograms of salmonella isolates at a tertiary care hospital in HyderabadIndian Journal of Medical Microbiology, 2006
- Typhoid Fever: A Massive, Single-Point Source, Multidrug-Resistant Outbreak in NepalClinical Infectious Diseases, 2005
- Widespread occurrence of multiple drug-resistantSalmonella typhi in IndiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992